-
公开(公告)号:EP3674309B1
公开(公告)日:2024-09-11
申请号:EP20157427.4
申请日:2013-04-12
IPC分类号: C07H3/04 , A61K31/7016 , A61K8/14
CPC分类号: A61K39/0007 , A61K2039/5557220130101 , A61K39/39 , C07H13/06 , A61P37/04
-
2.
公开(公告)号:EP4405042A1
公开(公告)日:2024-07-31
申请号:EP22787143.1
申请日:2022-09-22
发明人: HAAS, Mary E. , LOTTA, Luca Andrea , BARAS, Aris , FERREIRA, Manuel Allen Revez , LOCKE, Adam E. , BACKMAN, Joshua
IPC分类号: A61P13/12 , C12N15/113 , A61K31/341 , A61K31/7016 , C12Q1/32
-
公开(公告)号:EP4374866A1
公开(公告)日:2024-05-29
申请号:EP22846162.0
申请日:2022-07-18
发明人: PARK, Ok Nam
IPC分类号: A61K36/232 , A61K36/69 , A61K36/77 , A61K31/7016 , A61P17/02 , A61P19/02 , A61P29/00 , A61P17/06 , A61P31/04 , A61K8/9789
CPC分类号: A61P29/00 , A61P17/02 , A61P19/02 , A61K36/232 , A61K8/9789 , A61K36/77 , A61K31/7016 , A61K36/69 , A61P17/06 , A61P31/04
摘要: The present invention relates to a composition for preventing, improving or treating skin wound or inflammation. According to the present invention, since the composition is effective in treating not only general wound and inflammation occurring on the skin, but also chronic wound such as diabetic foot ulcers and bedsores, and chronic inflammation such as atopic dermatitis and psoriasis, the composition may be effectively used to prevent, improve, or treat skin wound or inflammation.
-
4.
公开(公告)号:EP3355894B1
公开(公告)日:2024-04-24
申请号:EP15905564.9
申请日:2015-09-29
IPC分类号: A61K31/7016 , A61K31/719 , A61K31/702 , A61K31/194 , A61P15/02 , A61K31/19 , A61K31/191 , A61K31/192 , A61K31/7004
CPC分类号: A61K31/194 , A61K31/7016 , A61K31/19 , A61K31/191 , A61K31/192 , A61P15/02 , Y02A50/30
-
-
公开(公告)号:EP3728283B1
公开(公告)日:2023-11-22
申请号:EP18842567.2
申请日:2018-12-19
IPC分类号: C07H21/02 , A61K31/7016 , A61P31/00 , A61P31/12 , A61P35/00
-
公开(公告)号:EP4271388A1
公开(公告)日:2023-11-08
申请号:EP21852039.3
申请日:2021-12-20
-
公开(公告)号:EP4217077A1
公开(公告)日:2023-08-02
申请号:EP21782526.4
申请日:2021-09-22
申请人: Beiersdorf AG
IPC分类号: A61Q19/00 , A61P17/10 , A61P17/00 , A61K8/60 , A61K8/73 , A61K8/365 , A61K8/42 , A61K8/44 , A61K8/37 , A61K8/92 , A61K31/19 , A61K31/17 , A61K31/195 , A61K31/215 , A61K31/7004 , A61K31/7016 , A61K31/702
-
9.
公开(公告)号:EP4216714A1
公开(公告)日:2023-08-02
申请号:EP21791567.7
申请日:2021-09-24
-
公开(公告)号:EP4183425A1
公开(公告)日:2023-05-24
申请号:EP22191523.4
申请日:2009-10-06
申请人: 3-D Matrix Ltd.
IPC分类号: A61L17/00 , A61L31/00 , A61P7/04 , A61L31/04 , A61L31/14 , C07K7/08 , A61K31/7004 , A61K31/7016 , A61K38/00
摘要: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like.
The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a β-structure in aqueous solution in the presence of physiological pH and/or a cation.
-
-
-
-
-
-
-
-
-